期刊文献+

带状疱疹后遗神经痛患者治疗前后白介素10水平与疼痛程度和持续时间的相关性分析

Correlation Between Interleukin-10 Levels Before and After Treatment and Pain Severity and Duration in Patients with Postherpetic Neuralgia
下载PDF
导出
摘要 目的分析带状疱疹后遗神经痛患者治疗前后白介素10(IL-10)水平与疼痛程度及持续时间的相关性。方法选取2020年6月至2021年12月我院收治的105例带状疱疹后遗神经痛患者,根据患者疼痛程度将患者分为轻中度组及重度组,比较两组患者白细胞、IL-10等实验室指标水平,患者出院后随访1年,记录患者疼痛持续时间,分析IL-10等指标水平与患者疼痛程度及持续时间的相关性。结果在随访期间4例患者失联,按脱落处理,最终纳入患者101例,其中轻中度组75例,重度组26例。两组患者年龄、性别等一般资料及治疗前后白细胞、中性粒细胞百分比水平相比较,差异无统计学意义(均P>0.05)。轻中度组疼痛评分、疼痛持续时间、治疗前超敏C-反应蛋白(Hs-CRP)及IL-10水平均显著低于重度组(t=28.408,23.888,2.726,9.381;均P<0.05);治疗后两组患者各指标均较前好转,但轻中度组患者Hs-CRP及IL-10水平仍显著低于重度组患者(t=4.342,5.966;均P<0.05)。相关性分析显示,治疗前、后IL-10水平与患者疼痛严重程度及持续时间呈显著正相关(r=0.705,0.209,0.739,0.481;均P<0.001);线性回归示,治疗前IL-10及Hs-CRP水平与患者疼痛持续程度显著相关(t=5.240,5.026;均P<0.05)。结论患者治疗前后IL-10水平与患者疼痛严重程度及疼痛持续时间显著相关,可成为患者预后的可靠预测因子,有助于评估患者预后。 Objective To analyze correlation between interleukin-10(IL-10)and the degree and duration of pain in patients with postherpetic neuralgia before and after treatment.Methods From June 2020 to December 2021,105 patients with postherpetic neuralgia admitted to our hospital were included.According to pain degree,patients were divided into mild-moderate and severe group.Age,gender and other general data were compared,and white blood cells,IL-10 and other laboratory indexes before and after treatment.Patients were followed up for one year after discharge,recording the duration of pain,analyzing the correlation between IL-10 and the degree and duration of pain.Results During the follow-up period,4 patients lost contact and were treated as falling off.Finally,101 patients were enrolled,including 75 patients in the mild-moderate group and 26 patients in severe group.There were no significant differences in age,gender and other general data between two groups,and the percentage of white blood cells and neutrophils before and after treatment(all P>0.05).The score,duration of pain,and hypersensitive C-reactive protein(Hs-CRP)and IL-10 before treatment in the mild-moderate group were significantly lower than those in severe group(t=28.408,23.888,2.726,9.381;all P<0.05).After treatment,all indexes of patients in two groups were improved,but Hs-CRP and IL-10 in mild-moderate group were significantly lower than those in severe group(t=4.342,5.966;all P<0.05).The correlation analysis showed that IL-10 before and after treatment was positively correlated with the severity and duration of pain(r=0.705,0.209,0.739,0.481;all P<0.001).The linear regression showed that IL-10 and Hs-CRP before treatment were significantly correlated with the pain duration of patients(t=5.240,5.026;all P<0.05).Conclusion IL-10 before and after treatment would be significantly correlated with the severity and duration of pain,which could be a reliable predictor of the prognosis of patients.
作者 迪丽白尔·塔力甫江 谢仁古丽·阿皮孜 王德全 Dilibaier Talipujiang;Xierenguli Apizi;Wang Dequan(Pain Diagnosis and Treatment Center,Xinjiang Uygur Autonomous Region People′s Hospital,Urumqi,Xinjiang 830000,China)
出处 《四川医学》 CAS 2024年第6期577-581,共5页 Sichuan Medical Journal
基金 新疆维吾尔自治区卫生健康青年医学科技人才专项科研项目(编号:WJWY-202125)。
关键词 带状疱疹 后遗神经痛 白介素-10 疼痛 herpes zoster postherpetic neuralgia interleukin-10 pain
  • 引文网络
  • 相关文献

参考文献4

二级参考文献98

  • 1Mills JA,Michel BA,Bloch DA,et al.The American College of Rheumatology 1990 criteria for The classification of HenochSchonlein purpura.Arthritis Rheum,1990,33:1114-1121.
  • 2Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25).Breakdown of a single mechanism of selftolerance causes various autoimmune diseases.J Immunol,1995,155:1151-1164.
  • 3Shevach EM.Certified professionals:CD4 (+) CD25 (+) suppressor T cells.J Exp Med,2001,193:41-46.
  • 4Gruox H.Type Ⅰ regulatory T cells:their role in the control of immune responses.Transplantation,2003,15:8-12.
  • 5Chen Y,Kuchroo VK,Inobe J,et al.Regulatory T cell clones induced by oral tolerance:suppression of autoimmune encephalomyelitis.Science,1994,265:1237-1240.
  • 6Cao D,Malmstrom V,Baecher-Allan C,et al.Isolation and functional characterization of regulatory CD+25 CD+4 T cells from the target organ of patients with rheumatoid arthritis.Eur J Immunol,2003,33:215-223.
  • 7Crispin JC,Martinez A,Alcocer-Varela J.Quantification of regulatory T cells in patients with systemic lupus erythematosus.J Autoimmun,2003,21:273-276.
  • 8Mottet C,Uhlig HH,Powrie F.Cutting edge:cure of colitis by CD4^+ CD25^+ regulatory T cells.J Immunol,2003,170:3939-3943.
  • 9Del Prete G,De Carli M,Almerigogna F,et al.Preferential expression of CD30 by human CD4 + T cells producing th2-type cytokines.FASEB J,1995,9:81-86.
  • 10Bennett CL,Christie J,Ramsdell F,et al.The immune dysregulation,polyendocrinopathy,enteropathy,X-linked syndrome (IPEX) is caused by mutations of FOXP3.Nat Genet,2001,27:20-21.

共引文献1106

;
使用帮助 返回顶部